We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDA icon
551
iShares MSCI India ETF
INDA
$6.71B
$1.15M 0.02%
+32,000
New +$1.11M
FRT icon
552
Federal Realty Investment Trust
FRT
$10.9B
$1.15M 0.02%
8,642
-6
-0.1% -$774
O icon
553
Realty Income
O
$61.2B
$1.13M 0.02%
20,375
TRGP icon
554
Targa Resources
TRGP
$60.4B
$1.12M 0.02%
23,116
+3,800
+20% +$170K
STLD icon
555
Steel Dynamics
STLD
$35.6B
$1.11M 0.02%
25,725
-2,967
-10% -$114K
ALLY icon
556
Ally Financial
ALLY
$13.1B
$1.09M 0.02%
37,471
NWL icon
557
Newell Brands
NWL
$2.16B
$1.07M 0.02%
34,665
-354
-1% -$12.2K
XENT
558
DELISTED
Intersect ENT, Inc
XENT
$1.07M 0.02%
+33,000
New +$990K
GT icon
559
Goodyear
GT
$2.07B
$1.06M 0.02%
32,884
-2,093
-6% -$66.5K
IMO icon
560
Imperial Oil
IMO
$62.1B
$1.06M 0.02%
33,767
-8,067
-19% -$251K
CPAY icon
561
Corpay
CPAY
$24.2B
$1.05M 0.02%
5,454
MRO
562
DELISTED
Marathon Oil Corporation
MRO
$1.05M 0.02%
61,859
+139
+0.2% +$2.06K
CIT
563
DELISTED
CIT Group Inc.
CIT
$1.04M 0.02%
21,166
CNP icon
564
CenterPoint Energy
CNP
$29.1B
$1.02M 0.02%
36,160
+6,972
+24% +$203K
TAP icon
565
Molson Coors Class B
TAP
$7.68B
$1.02M 0.02%
12,485
-319
-2% -$25.8K
TCOM icon
566
Trip.com Group
TCOM
$27.5B
$1.02M 0.02%
23,245
PRTK
567
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.02M 0.02%
57,000
-106,000
-65% -$2.21M
ANSS
568
DELISTED
Ansys
ANSS
$1.02M 0.02%
6,904
+82
+1% +$11.6K
AGNC icon
569
AGNC Investment
AGNC
$12.3B
$1.02M 0.02%
50,332
+7,004
+16% +$144K
CALA
570
DELISTED
Calithera Biosciences, Inc
CALA
$1M 0.02%
6,000
-5,000
-45% -$1.28M
MLM icon
571
Martin Marietta Materials
MLM
$33.6B
$981K 0.02%
4,438
EXPE icon
572
Expedia Group
EXPE
$31.2B
$980K 0.02%
8,184
+47
+0.6% +$6.1K
LNG icon
573
Cheniere Energy
LNG
$56.5B
$976K 0.02%
18,122
-1,346
-7% -$64.9K
GPN icon
574
Global Payments
GPN
$22.1B
$974K 0.02%
9,712
-1,187
-11% -$119K
CTRA
575
DELISTED
Coterra Energy
CTRA
$971K 0.02%
33,960

Similar funds

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.